Virtu KCG Holdings LLC raised its position in shares of Steris Plc (NYSE:STE) by 72.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,288 shares of the medical equipment provider’s stock after buying an additional 4,337 shares during the period. Virtu KCG Holdings LLC’s holdings in Steris Plc were worth $838,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bragg Financial Advisors Inc bought a new position in shares of Steris Plc in the first quarter valued at approximately $1,159,000. State of Wisconsin Investment Board acquired a new position in shares of Steris Plc in the 2nd quarter worth approximately $1,360,000. Morgan Stanley boosted its holdings in shares of Steris Plc by 28.3% in the 1st quarter. Morgan Stanley now owns 266,537 shares of the medical equipment provider’s stock worth $18,514,000 after acquiring an additional 58,776 shares in the last quarter. Legal & General Group Plc boosted its holdings in shares of Steris Plc by 31.0% in the 1st quarter. Legal & General Group Plc now owns 56,190 shares of the medical equipment provider’s stock worth $3,902,000 after acquiring an additional 13,294 shares in the last quarter. Finally, Capstone Asset Management Co. boosted its holdings in shares of Steris Plc by 36.1% in the 2nd quarter. Capstone Asset Management Co. now owns 8,560 shares of the medical equipment provider’s stock worth $698,000 after acquiring an additional 2,270 shares in the last quarter. 93.33% of the stock is owned by institutional investors.

A number of equities research analysts recently commented on the company. Zacks Investment Research lowered Steris Plc from a “buy” rating to a “hold” rating in a research report on Tuesday, August 22nd. Raymond James Financial, Inc. raised their price target on Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, August 9th. Finally, BidaskClub downgraded Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $86.75.

In other news, Director Richard Martin Steeves sold 156,072 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $87.13, for a total value of $13,598,553.36. Following the completion of the transaction, the director now owns 9,362 shares of the company’s stock, valued at $815,711.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mohsen Sohi sold 2,744 shares of the company’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $85.98, for a total value of $235,929.12. Following the completion of the transaction, the director now directly owns 21,816 shares of the company’s stock, valued at approximately $1,875,739.68. The disclosure for this sale can be found here. Insiders sold a total of 172,086 shares of company stock valued at $14,971,621 over the last quarter. 2.55% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/steris-plc-ste-stake-increased-by-virtu-kcg-holdings-llc/1607559.html.

Shares of Steris Plc (STE) opened at 89.64 on Wednesday. The company has a market cap of $7.64 billion, a price-to-earnings ratio of 64.12 and a beta of 1.29. The firm’s 50-day moving average is $86.70 and its 200-day moving average is $79.66. Steris Plc has a one year low of $63.80 and a one year high of $89.67.

Steris Plc (NYSE:STE) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The company had revenue of $608.00 million for the quarter, compared to the consensus estimate of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The firm’s quarterly revenue was down 4.8% compared to the same quarter last year. During the same period last year, the company posted $0.79 EPS. Analysts expect that Steris Plc will post $4.06 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th were issued a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, August 25th. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a dividend yield of 1.38%. Steris Plc’s dividend payout ratio is 88.57%.

Steris Plc Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Institutional Ownership by Quarter for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.